Cargando…
Clinical efficacy and safety of Ganshuang granules as an adjuvant treatment for chronic hepatitis B liver fibrosis: A protocol for systematic review and meta analysis
BACKGROUND: Chronic hepatitis B liver fibrosis is significant public concern. Ganshuang granules (GSG) are used to treat liver fibrosis for a long time. The aim of this study is to synthesize related data to explore efficacy and safety of GSG as an adjuvant treatment for chronic hepatitis B liver fi...
Autores principales: | Zeng, Shaoqian, Liu, Yefang, Jiang, Cen, Li, Baixue, Wen, Li, Feng, Quansheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544267/ https://www.ncbi.nlm.nih.gov/pubmed/33031339 http://dx.doi.org/10.1097/MD.0000000000022692 |
Ejemplares similares
-
The effect of acupoint application of traditional Chinese medicine for the treatment of chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Liu, Yefang, et al.
Publicado: (2020) -
The efficacy of Qigong exercises for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis
por: Liu, Yuqiao, et al.
Publicado: (2020) -
Naringin in Ganshuang Granule suppresses activation of hepatic stellate cells for anti‐fibrosis effect by inhibition of mammalian target of rapamycin
por: Shi, Hongbo, et al.
Publicado: (2016) -
Clinical study of ganshuang granule combined with tenofovir in the treatment of chronic hepatitis B complicated with nonalcoholic fatty liver disease
por: Su, Changtian, et al.
Publicado: (2022) -
The efficacy and safety of sulforaphane as an adjuvant in the treatment of bipolar depressive disorder: Study protocol for a randomized, double-blinded, placebo-controlled, parallel-group clinical trial
por: Wu, Congchong, et al.
Publicado: (2020)